Unlock instant, AI-driven research and patent intelligence for your innovation.

Stem cells for transplantation and manufacturing method therefor

a technology of stem cells and stem cells, applied in the field of stem cells for transplantation, can solve the problems of inability to stably express a therapeutic gene, difficult to maintain, etc., and achieve the effects of convenient production of high post-transplantation engraftment rate, high post-transplantation cell survival rate and engraftment rate, and high safety

Inactive Publication Date: 2018-11-22
NAT CENT OF NEUROLOGY & PSYCHIATRY
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patent describes a new type of stem cell that can be used for transplantation purposes. These stem cells have a high survival rate and can engraft with other cells in the body, making them highly safe. The patent also describes a method for producing these stem cells, as well as an agent that can enhance their performance. Additionally, the patent discusses the use of these stem cells to induce immunological tolerance and suppress rejection in the body, resulting in improved cell survival and engraftment.

Problems solved by technology

Nonetheless, MSCs present major problems: the cells have an unstable post-transplantation survival rate or engraftment rate and therefore tend to result in graft failure; and their original properties are difficult to maintain over a long period.
Hence, the previous autologous transplantation therapy using MSCs has failed to stably express a therapeutic gene.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stem cells for transplantation and manufacturing method therefor
  • Stem cells for transplantation and manufacturing method therefor
  • Stem cells for transplantation and manufacturing method therefor

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0148](Objective)

[0149]The objective is to verify the effect of improving the survival rate of MSCs after the intracellular expression level of IL-10 in MSCs was increased by use of an IL-10 expression plasmid, and an IL-10 concentration in serum.

[0150](Method)

[0151]1. Gene Transfection of MSCs with IL-10 Expression Plasmid DNA

[0152]2 μg of a mouse IL-10 expression plasmid DNA (pW-CAG-mIL-10-WPRE) or a control GFP expression plasmid DNA (pW-CAG-EGFP-WPRE) was mixed with 100 μL of a Nucleofection solution (Human MSC Nucleofector kit, Lonza Group Ltd.) / 5×105 MSCs, and each mixture was used in gene transfection using an Amaxa Nucleofector system (C-17 mode). The pW-CAG-mIL-10-WPRE was prepared by introducing the recombinant mouse IL-10 gene prepared in Comparative Example 2 to the BamHI site of pW-CAG-WPRE. The pW-CAG-EGFP-WPRE was prepared by introducing an EGFP gene to the BamHI site of pW-CAG-WPRE (Okada, T., et al., 2005, Hum. Gene Ther., 16: 1212-1218). The detailed procedures fol...

example 2

[0162](Objective)

[0163]The objective is to verify the effect of improving the survival rate and engraftment rate of MSCs after the intracellular expression level of IL-10 in the MSCs was increased by use of an IL-10 expression AAV vector.

[0164](Method)

[0165]1. Gene Transfection of MSCs with AAV Vector and Confirmation of Expression

[0166]The recombinant AAV was prepared according to the method described in Comparative Example 2. SD-rat MSCs-Luc was inoculated at 1×105 cells / well to a 24 well-plate (IWAKI / AGC Techno Glass Co., Ltd.) containing a DMED / F-12 (1:1) medium containing 10% FBS. After cell adhesion, an unpurified culture supernatant containing the mouse IL-10 expression AAV vector AAV1-IL-10 or a GFP expression AAV vector AAV1-CAG-EGFP-WPRE(EW) (hereinafter, referred to as “AAV1-GFP”) at 5.0×1010 g.c. was added thereto for the gene transfection of the SD-rat MSCs. After overnight culture at 37° C. in the presence of 5% CO2, the medium was replaced with a fresh one every 2 day...

example 3

[0178]

[0179](Objective)

[0180]The objective is to verify, in dogs, the effect of improving the survival and engraftment rates of AAV1-IL-10-introduced MSCs, which was demonstrated in mice.

[0181](Method)

[0182]1. Preparation of Dog Bone Marrow-Derived MSCs

[0183]Donor and recipient dogs were selected from DLA (dog leukocyte antigen)-matched male and female pairs of beagles. As illustrated in FIG. 8, 2 mL of a bone marrow fluid was collected from the fore-leg right and left upper arms of the donor normal dog. The bone marrow fluid was cultured in 2 mL of RPMI-1640 (Life Technologies Corporation) containing 20 U / mL heparin. Monocytes were isolated (1.3×108 cells) under a density gradient using Histopaque-1077 (Sigma-Aldrich Corp.). Then, a CD271-positive fraction having the high ability to grow (MSC Research Tool Box-CD271 (LNGFR) containing CD271 (LNGFR)-PE & Anti-PE Micro Beads (Miltenyi Biotec) was concentrated using immuno-magnetic beads (MACS® Columns and MACS Separators, Miltenyi Bi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
volumeaaaaaaaaaa
volumeaaaaaaaaaa
Login to View More

Abstract

It is intended to provide MSCs for transplantation that have an improved post-transplantation cell survival rate and engraftment rate and are highly safe with fewer adverse reactions, and a method for conveniently producing MSCs for transplantation having a high cell survival rate and engraftment rate. As means therefor, the present invention provides a stem cell for transplantation comprising an MSC capable of overexpressing IL-10.

Description

RELATED APPLICATIONS[0001]This application is a continuation application of patent application Ser. No. 14 / 892,474, filed Nov. 19, 2015, which is a 371 application of International Application No. PCT / JP2014 / 063448, having an international filing date of May 21, 2014, which claims priority to Japanese Patent Application No. 2013-108408, filed May 22, 2013, contents of which are incorporated herein by reference in their entirety.TECHNICAL FIELD[0002]The present invention relates to a mesenchymal stem cell for transplantation having a high survival rate and engraftment rate in cell transplantation, a method for producing the mesenchymal stem cells for transplantation, and an agent enhancing post-transplantation mesenchymal stem cell engraftment.BACKGROUND ART[0003]Mesenchymal stem cells (hereinafter, also abbreviated to “MSCs” in the present specification) are somatic stem cells having the ability to differentiate into cells belonging to the mesenchyme. MSCs are considered as the most...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K38/20C12N5/0775
CPCC12N5/0662A61K38/2066A61K48/00C07K14/5428C12N2750/14171C12N7/00A61L27/3834C12N2510/00C12N2750/14143C12N2510/02C12N2501/231C12N5/0663A61K35/28C12N15/86A61P37/06A61K39/001A61K2039/577A61K2039/552A61P1/16A61P19/04A61P21/00A61P25/00A61P9/00A61K2300/00
Inventor OKADA, TAKASHIKASAHARA, YUKOTAKEDA, SHINICHI
Owner NAT CENT OF NEUROLOGY & PSYCHIATRY